829.43
price up icon0.07%   0.59
after-market Dopo l'orario di chiusura: 829.44 0.01 +0.00%
loading

Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie

pulisher
04:59 AM

Regeneron Pharmaceuticals exec sells shares worth $844,610 - Investing.com

04:59 AM
pulisher
09:00 AM

Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - Yahoo Finance

09:00 AM
pulisher
08:38 AM

Central Bank & Trust Co. Acquires 650 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

08:38 AM
pulisher
Nov 04, 2024

StockNews.com Downgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Buy - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

This Is What Whales Are Betting On Regeneron Pharmaceuticals - Benzinga

Nov 04, 2024
pulisher
Nov 04, 2024

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors - Business Wire

Nov 04, 2024
pulisher
Nov 04, 2024

Urticaria Clinical Trial Pipeline Accelerates: 20+ Leading Companies Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

Nov 04, 2024
pulisher
Nov 04, 2024

TD Cowen maintains Buy on Regeneron shares, sees growth in Eylea HD - Investing.com

Nov 04, 2024
pulisher
Nov 04, 2024

Regeneron Pharmaceuticals reports new FKBP1A ligands - BioWorld Online

Nov 04, 2024
pulisher
Nov 04, 2024

Van ECK Associates Corp Acquires 4,742 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

A Decade On, How Deep Do Regeneron’s Oncology Foundations Go? - Citeline

Nov 04, 2024
pulisher
Nov 04, 2024

Regeneron Takes A Ghastly Turn As High-Dose Eylea Lags And Biosimilars Loom - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Regeneron: Buying A Promising Pipeline At A Fair Price (Rating Upgrade) (NASDAQ:REGN) - Seeking Alpha

Nov 04, 2024
pulisher
Nov 03, 2024

4,785 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by Empire Life Investments Inc. - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 02, 2024
pulisher
Nov 02, 2024

Regeneron price target lowered to $1,126 from $1,137 at Truist - Yahoo Finance

Nov 02, 2024
pulisher
Nov 02, 2024

BMO cuts Regeneron target on Eylea HD miss, competition concerns By Investing.com - Investing.com Australia

Nov 02, 2024
pulisher
Nov 01, 2024

AMGN: 3 Biotechnology Stocks With Promising Pipelines - StockNews.com

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 01, 2024
pulisher
Nov 01, 2024

The Law Offices of Frank R. Cruz Continues Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors - Business Wire

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Trimmed by New York State Common Retirement Fund - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

BMO cuts Regeneron target on Eylea HD miss, competition concerns - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity? - Insider Monkey

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Cut to $1,195.00 by Analysts at Piper Sandler - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Analyst recommendations: Amazon.com, Mastercard, Bristol-Myers Squibb Company, Uber Technologies, Regeneron Pharmaceuticals... - Marketscreener.com

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron Reports Mixed Q3 Sales as Eylea Franchise Remains Under Pressure - BioSpace

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron: Investors In Panic Mode On Increased Eylea Fears (NASDAQ:REGN) - Seeking Alpha

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron battles Wall Street uncertainty; Madrigal extends fast launch of MASH drug - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron Pharmaceuticals Inc (REGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Q3 2024 Regeneron Pharmaceuticals Inc Earnings Call - AOL

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron Pharmaceuticals Inc (REGN) Q3 2024 Earnings Call Highl - GuruFocus.com

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron: Q3 Earnings Snapshot - The Advocate

Nov 01, 2024
pulisher
Nov 01, 2024

Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight - Yahoo Finance

Nov 01, 2024
pulisher
Nov 01, 2024

Regeneron Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks

Nov 01, 2024
pulisher
Oct 31, 2024

Regeneron Shares Drop After Sales of Higher-Dose Eylea Miss Expectations - MarketWatch

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron Pharmaceuticals Files For Mixed Shelf - XM

Oct 31, 2024
pulisher
Oct 31, 2024

Evercore ISI cuts Regeneron target to $1,170 from $1,175 - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

Evercore ISI cuts Regeneron target to $1,170 from $1,175 By Investing.com - Investing.com UK

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron Earnings Top Views For Biotech Giant - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Eylea headwinds said to be behind Regeneron’s post-Q3 plunge - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: Regeneron reports robust Q3 growth, Dupixent shines By Investing.com - Investing.com Canada

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: Regeneron reports robust Q3 growth, Dupixent shines - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron stock falls on Eylea headwinds (REGN:NASDAQ) - Seeking Alpha

Oct 31, 2024
pulisher
Oct 31, 2024

Why Is Regeneron Pharmaceuticals Stock Trading Lower Today? - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron Pharmaceuticals Down Nearly 10%, on Track for Largest Percent Decrease Since March 2020 — Data Talk - Morningstar

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron's Eylea HD makes progress but doesn't dent the momentum of Roche's Vabysmo - FiercePharma

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron shares drop as higher-dose Eylea drug misses sales estimates - Reuters

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron third-quarter 2024 earnings top expectations - The Pharma Letter

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron down 10% despite top and bottom line beats - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron: Adjusted EPS& up 8% in Q3 - Marketscreener.com

Oct 31, 2024
pulisher
Oct 31, 2024

REGN Q3 Earnings and Revenues Beat on Strong Eylea HD & Dupixent Sales - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron Pharmaceuticals Q3 2024 Earnings: EPS Soars to $11.54, - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Oak Harvest Investment Services Purchases 567 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron beats results estimates on demand for eczema treatment, eye drug - Marketscreener.com

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron Q3 earnings top estimates, revenue up 11% YoY - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Regeneron Reports Third Quarter 2024 Financial and Operating Results - The Manila Times

Oct 31, 2024
$499.88
price up icon 5.73%
$602.47
price up icon 2.34%
$265.29
price down icon 1.73%
$110.97
price up icon 1.84%
$208.03
price up icon 0.38%
Capitalizzazione:     |  Volume (24 ore):